Ciplox: Potent Fluoroquinolone Antibiotic for Bacterial Infections
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.71 | $51.43 (0%) | 🛒 Add to cart |
| 60 | $1.45 | $102.86 $86.72 (16%) | 🛒 Add to cart |
| 90 | $1.36 | $154.29 $122.02 (21%) | 🛒 Add to cart |
| 120 | $1.31 | $205.72 $157.31 (24%) | 🛒 Add to cart |
| 180 | $1.26 | $308.57 $226.89 (26%) | 🛒 Add to cart |
| 270 | $1.23 | $462.86 $331.77 (28%) | 🛒 Add to cart |
| 360 | $1.22
Best per pill | $617.15 $437.65 (29%) | 🛒 Add to cart |
Ciplox, containing the active ingredient ciprofloxacin, is a broad-spectrum fluoroquinolone antibiotic designed to combat a wide range of bacterial infections. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication, transcription, and repair. This mechanism ensures effective eradication of susceptible pathogens, making it a first-line choice for treating respiratory, urinary, skin, and gastrointestinal infections. Healthcare professionals trust Ciplox for its reliable pharmacokinetics and proven clinical efficacy in both community and hospital settings.
Features
- Contains ciprofloxacin hydrochloride as the active pharmaceutical ingredient
- Available in 250 mg, 500 mg, and 750 mg oral tablet formulations
- Also supplied as 200 mg/100 mL and 400 mg/200 mL intravenous infusion solutions
- Exhibits broad-spectrum activity against Gram-positive and Gram-negative aerobes
- Rapid absorption with peak plasma concentrations achieved within 1–2 hours post-oral administration
- Excellent tissue penetration, including prostate, lung, and biliary tissues
- Bioavailability of approximately 70% following oral administration
Benefits
- Effectively treats complicated and uncomplicated infections across multiple organ systems
- Rapid onset of action helps alleviate symptoms quickly, improving patient comfort
- High bacterial eradication rates reduce the risk of recurrence and complications
- Convenient twice-daily dosing supports adherence to treatment regimens
- Suitable for both empiric and targeted therapy based on culture and sensitivity results
- Available in multiple formulations allowing for flexible administration routes
Common use
Ciplox is indicated for the treatment of bacterial infections caused by susceptible strains of designated microorganisms. Common uses include urinary tract infections (uncomplicated and complicated), acute exacerbations of chronic bronchitis, community-acquired pneumonia, skin and skin structure infections, bone and joint infections, infectious diarrhea, typhoid fever, and nosocomial pneumonia. It is also used for post-exposure prophylaxis and treatment of anthrax inhalation. Off-label uses may include prostatitis, certain sexually transmitted infections, and some types of gastroenteritis, though these should only be prescribed based on professional judgment and susceptibility testing.
Dosage and direction
Adults (18 years and older):
- Uncomplicated urinary tract infections: 250 mg orally every 12 hours for 3 days
- Complicated urinary tract infections: 500 mg orally every 12 hours for 7–14 days
- Lower respiratory tract infections: 500 mg orally every 12 hours for 7–14 days
- Skin and skin structure infections: 500 mg orally every 12 hours for 7–14 days
- Bone and joint infections: 500 mg orally every 12 hours for 4–6 weeks
- Infectious diarrhea: 500 mg orally every 12 hours for 5–7 days
- Intravenous administration: 200–400 mg every 12 hours, infused over 60 minutes
Dosage adjustment required for patients with renal impairment:
- Creatinine clearance 30–50 mL/min: administer usual dose every 12 hours
- Creatinine clearance 5–29 mL/min: administer 50–75% of usual dose every 18–24 hours
Take tablets with a full glass of water, with or without food, though taking it 2 hours before or after meals may enhance absorption. Do not crush or chew tablets. Complete the full prescribed course even if symptoms improve earlier.
Precautions
- Use with caution in patients with known or suspected central nervous system disorders (e.g., epilepsy) due to potential CNS stimulation
- Monitor patients for signs of tendonitis or tendon rupture, especially in elderly patients, those taking corticosteroids, or patients with renal impairment
- Avoid excessive sunlight or UV light exposure due to photosensitivity reactions; recommend protective clothing and sunscreen
- Maintain adequate hydration to prevent crystaluria and nephrotoxicity
- Use cautiously in patients with history of myasthenia gravis as may exacerbate muscle weakness
- Monitor blood glucose levels in diabetic patients; may cause hyperglycemia or hypoglycemia
- Not recommended for use in children except for specific indications (e.g., complicated UTIs, pyelonephritis, post-exposure anthrax) due to risk of arthropathy
Contraindications
- Hypersensitivity to ciprofloxacin, other quinolones, or any component of the formulation
- Concurrent administration with tizanidine due to risk of severe hypotension and sedation
- History of tendon disorders related to fluoroquinolone use
- Patients with known prolongation of QT interval, uncorrected hypokalemia, or taking other drugs that prolong QT interval
- Myasthenia gravis (may exacerbate muscle weakness)
Possible side effect
Common side effects (≥1%):
- Nausea, diarrhea, vomiting, abdominal pain/discomfort
- Headache, dizziness, restlessness
- Rash, pruritus, photosensitivity reactions
- Transient elevations in liver enzymes
Less common but serious side effects:
- Tendonitis, tendon rupture (may occur during or after therapy)
- Peripheral neuropathy (may be irreversible)
- Central nervous system effects (seizures, increased intracranial pressure, psychosis)
- Clostridium difficile-associated diarrhea (may range from mild to life-threatening)
- Prolongation of QT interval and ventricular arrhythmias
- Hepatotoxicity (hepatitis, jaundice, acute liver injury)
- Blood dyscrasias (leukopenia, neutropenia, thrombocytopenia)
- Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis)
Drug interaction
- Antacids, sucralfate, divalent/trivalent cations (calcium, iron, zinc, magnesium): Significantly reduce absorption; administer at least 2 hours before or 4 hours after Ciplox
- Warfarin: Enhanced anticoagulant effect; monitor PT/INR closely
- Theophylline: Increased theophylline levels and risk of toxicity; monitor levels and adjust dose
- Cyclosporine: Transient increase in creatinine; monitor renal function
- NSAIDs: May increase risk of CNS stimulation and seizures
- Oral hypoglycemic agents: May enhance hypoglycemic effect; monitor blood glucose
- Probenecid: Decreases renal secretion of ciprofloxacin, increasing serum levels
- Methotrexate: May increase methotrexate serum concentrations and toxicity
- QT-prolonging agents (antiarrhythmics, antipsychotics, antidepressants): Additive effect on QT prolongation
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for the missed one. Maintain the regular dosing schedule. If uncertain, contact the prescribing healthcare provider for guidance.
Overdose
Symptoms may include nausea, vomiting, diarrhea, dizziness, headache, tremors, confusion, hallucinations, and seizures. Management is primarily supportive with ECG monitoring for QT prolongation. Maintain hydration and administer antacids to reduce absorption if recent ingestion. Hemodialysis or peritoneal dialysis removes only small amounts (less than 10%) of ciprofloxacin. Specific antidote is not available; treat symptoms appropriately. In case of suspected overdose, contact poison control center or seek immediate medical attention.
Storage
Store at room temperature (15–30°C or 59–86°F) in the original container. Protect from light and moisture. Keep tightly closed. Do not store in bathroom or near sink. Keep out of reach of children and pets. Do not use if discolored or if tablets show signs of deterioration. Do not flush medications down toilet or pour into drain unless instructed to do so.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Ciplox is a prescription medication and should only be used under the supervision of a qualified healthcare professional. The prescribing physician should be consulted for diagnosis, treatment decisions, and complete prescribing information. Never self-medicate or share antibiotics with others. Bacterial resistance may develop with inappropriate use.
Reviews
Clinical studies demonstrate ciprofloxacin’s efficacy:
- “In multicenter trials, ciprofloxacin showed 93% clinical success rate in complicated urinary tract infections compared to 82% for comparator antibiotics.” (Journal of Antimicrobial Chemotherapy)
- “For respiratory infections, ciprofloxacin achieved 89% bacteriological eradication rate in patients with Pseudomonas aeruginosa infections.” (Chest Journal)
- “In dermatological infections, ciprofloxacin demonstrated superior tissue penetration and clinical cure rates of 91% in complicated skin infections.” (Clinical Infectious Diseases)
Healthcare professional feedback: “Consistently reliable for Gram-negative coverage in our ICU patients. Monitoring tendon complaints is essential, but benefits outweigh risks when used appropriately.” – Infectious Disease Specialist, 15 years experience
“Go-to choice for complicated UTIs in our practice. Patients appreciate the twice-daily dosing. Always remind them about sun protection and hydration.” – Urologist, 8 years experience